Amanta Healthcare Quarterly Results for Trading Insights
AMANTA • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹11 Cr
QMarch 2025
Amanta Healthcare Quarterly Results Key Highlights
- Revenue of ₹276 Cr in March 2025 (+0.0% vs March 2025, -2.1% vs March 2024)
- Net Profit of ₹11 Cr in March 2025 (+0.0% vs March 2025, +175.0% vs March 2024)
- EBITDA of ₹61 Cr in March 2025 (+0.0% vs March 2025)
- Operating Margin of 22.0% in March 2025 (+0.0pp vs March 2025)
- Earnings Per Share of ₹3.71 in March 2025 (+0.0% vs March 2025)
Amanta Healthcare Quarterly Results Analysis
| Metric | 2026 | March 2025 | March 2024 | March 2023 | March 2022 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 285 | 276 | 282 | 263 | 227 | 3.3% | - |
| Net Profit (₹ Cr) | 15 | 11 | 4 | -2 | 55 | - | - |
| EBITDA (₹ Cr) | 63 | 61 | 59 | 56 | 54 | - | - |
| EPS (₹) | 5.00 | 3.71 | 1.35 | -0.79 | 20.54 | - | - |
| Operating Margin (%) | 22.0% | 22.0% | 21.0% | 20.0% | 23.0% | - | - |
Amanta Healthcare Share Price Trend Around Quarterly Results
Visualize Amanta Healthcare's 1-year price movement across quarterly results — ideal for logging trades in Amanta Healthcare share price
chart using Tickjournal. All values in ₹.
Related Pages for Amanta Healthcare
Additional stock information and data for AMANTA
Revenue Trend (₹ Cr)
March 2023
263
March 2024
282
March 2025
276
2026
285
Net Profit Trend (₹ Cr)
March 2023
-2
March 2024
4
March 2025
11
2026
15
Operating Margin Trend (%)
March 2023
20.0%
March 2024
21.0%
March 2025
22.0%
2026
22.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Amanta Healthcare quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹416,764.48 Cr | 1750.5 | 14,875 | 3,125 | +10.8% | - | 21.0% | 134.7 |
|
Divis Laboratories
Sept 2025 |
₹170,125.54 Cr | 6316.0 | 2,860 | 689 | +7.1% | - | 24.1% | 243.2 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹146,658.56 Cr | 4341.0 | 3,219 | 591 | +11.3% | - | 18.4% | 247.5 |
|
Cipla
Sept 2025 |
₹109,178.44 Cr | 1313.2 | 7,716 | 1,353 | +12.0% | - | 17.5% | 78.5 |
|
Dr Reddys Laborator…
Sept 2025 |
₹107,358.50 Cr | 1291.2 | 9,135 | 1,337 | +1.1% | - | 14.6% | 79.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores